KAT2B and cataract: Specific inhibitors of these proteins, including CPTH2, an inhibitor of Gcn5 [36]; Embelin, a p/CAF inhibitor [37]; TH1834, a Tip60 inhibitor [37]; and C646 and CBP30, both CBP/p300 inhibitors [37], prevent galactose-induced cataracts [15].